Cortrosyn

Iritis, Ophthalmia, Sympathetic, Pemphigus + 22 more
Treatment
25 FDA approvals
20 Active Studies for Cortrosyn

What is Cortrosyn

TetracosactideThe Generic name of this drug
Treatment SummaryTetracosactide (also known as Cosyntropin) is a synthetic hormone that is identical to a segment of the natural hormone adrenocorticotropic hormone (ACTH). This peptide works in the same way as natural ACTH, stimulating the production of corticosteroids in the adrenal cortex. Tetracosactide is absorbed over a longer period of time than natural ACTH, so treatment can be continued with less frequent doses.
Cortrosynis the brand name
image of different drug pills on a surface
Cortrosyn Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Cortrosyn
Tetracosactide
2003
10

Approved as Treatment by the FDA

Tetracosactide, also known as Cortrosyn, is approved by the FDA for 25 uses which include Adrenal Insufficiency and Panhypopituitarism .
Adrenal Insufficiency
Panhypopituitarism
Helps manage Panhypopituitarism
Lupus Erythematosus
Helps manage Lupus Erythematosus
Rheumatoid Arthritis
Helps manage Rheumatoid Arthritis
exfoliative erythroderma
Helps manage exfoliative erythroderma
Acute Rheumatic Fever
Helps manage Acute Rheumatic Fever
Jaundice, Hemolytic
Helps manage acquired hemolytic jaundice
Nephrotic Syndrome
Helps manage Nephrotic Syndrome
Still's Disease
Helps manage Still's Disease
Multiple Sclerosis
Helps manage Multiple sclerosis exacerbation
Ophthalmia, Sympathetic
Helps manage Ophthalmia, Sympathetic
Psoriatic Arthritis
Helps manage Psoriatic Arthritis
Ankylosing Spondylitis
Helps manage Ankylosing Spondylitis (AS)
Dermatomyositis (DM)
Helps manage Dermatomyositis (DM)
Periarteritis nodosa
Helps manage Periarteritis nodosa
Uveitis
Helps manage Uveitis
Arthritis, Gouty
Iritis
Helps manage Iritis
Pemphigus
Helps manage Pemphigus
Bell's Palsy
Helps manage Bell's Palsy
Scleroderma
Helps manage Scleroderma
Pink Eye
Helps manage Conjunctivitis
Optic Neuritis
Helps manage Optic Neuritis
Choroiditis
Helps manage Choroiditis
Ulcerative Colitis
Helps manage Ulcerative Colitis

Effectiveness

How Cortrosyn Affects PatientsCosyntropin is a synthetic form of ACTH (adrenocorticotropic hormone) that has similar effects to natural ACTH, with the potential to stimulate the adrenal cortex. The effects of Cosyntropin are maximized at 0.25 milligrams (mg) and are comparable to the effects of 25 units of natural ACTH. Cosyntropin is less likely to cause an allergic reaction than natural ACTH, as it lacks part of the amino acid sequence that is responsible for causing an immune response. In addition to stimulating the adrenal cortex, Cosyntropin may also increase melanin production and
How Cortrosyn works in the bodyCosyntropin connects to a receptor on the cells in the adrenal gland. This connection stimulates the production of hormones, like cortisol and aldosterone, from cholesterol. In people with healthy adrenal glands, cosyntropin increases the amount of hormones produced. However, it won't have much effect on those with adrenal insufficiency.

When to interrupt dosage

The endorsed portion of Cortrosyn is contingent upon the diagnosed condition, including Exfoliative dermatitis, Arthritis, Gouty and Uveitis. The dosage fluctuates based on the method of administration (e.g. Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral or Injection, solution) as seen in the table below.
Condition
Dosage
Administration
Panhypopituitarism
, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous
Ulcerative Colitis
, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous
Iritis
, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous
Scleroderma
, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous
Bell's Palsy
, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous
Pink Eye
, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous
Multiple Sclerosis
, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous
exfoliative erythroderma
, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous
Acute Rheumatic Fever
, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous
Psoriatic Arthritis
, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous
Jaundice, Hemolytic
, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous
Ophthalmia, Sympathetic
, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous
Nephrotic Syndrome
, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous
Uveitis
, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous
Choroiditis
, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous
Periarteritis nodosa
, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous
Optic Neuritis
, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous
Dermatomyositis (DM)
, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous
Adrenal Insufficiency
, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous
Lupus Erythematosus
, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous

Warnings

Cortrosyn has twelve contraindications and should not be employed when experiencing any of the conditions appearing in the following table.Cortrosyn Contraindications
Condition
Risk Level
Notes
Asthma
Do Not Combine
Hypersensitivity
Do Not Combine
Mycoses
Do Not Combine
Virus Diseases
Do Not Combine
Cushing's Syndrome
Do Not Combine
Adrenogenital Syndrome
Do Not Combine
Congestive heart failure
Do Not Combine
Peptic Ulcer
Do Not Combine
Addison Disease
Do Not Combine
Psychotic Disorders
Do Not Combine
Pulse Frequency
Do Not Combine
Bacterial Infections
Do Not Combine
There are 20 known major drug interactions with Cortrosyn.
Common Cortrosyn Drug Interactions
Drug Name
Risk Level
Description
Valproic acid
Major
Tetracosactide may increase the hepatotoxic activities of Valproic acid.
7-Nitroindazole
Moderate
The risk or severity of liver damage can be increased when Tetracosactide is combined with 7-Nitroindazole.
Acetazolamide
Moderate
The risk or severity of liver damage can be increased when Tetracosactide is combined with Acetazolamide.
Amobarbital
Moderate
The risk or severity of liver damage can be increased when Tetracosactide is combined with Amobarbital.
Barbexaclone
Moderate
The risk or severity of liver damage can be increased when Tetracosactide is combined with Barbexaclone.
image of a doctor in a lab doing drug, clinical research

Cortrosyn Novel Uses: Which Conditions Have a Clinical Trial Featuring Cortrosyn?

222 active trials are currently being conducted to determine the potential of Cortrosyn in alleviating symptoms of Choroiditis, Multiple Sclerosis and Sympathetic Ophthalmia.
Condition
Clinical Trials
Trial Phases
Choroiditis
0 Actively Recruiting
Iritis
0 Actively Recruiting
Dermatomyositis (DM)
1 Actively Recruiting
Phase 1
Periarteritis nodosa
0 Actively Recruiting
Ophthalmia, Sympathetic
0 Actively Recruiting
Multiple Sclerosis
0 Actively Recruiting
exfoliative erythroderma
0 Actively Recruiting
Uveitis
15 Actively Recruiting
Phase 2, Phase 3, Phase 4, Not Applicable, Phase 1
Optic Neuritis
3 Actively Recruiting
Phase 3, Not Applicable, Phase 2
Ankylosing Spondylitis
2 Actively Recruiting
Phase 3, Not Applicable
Pink Eye
5 Actively Recruiting
Phase 4, Phase 3, Not Applicable, Phase 2
Psoriatic Arthritis
20 Actively Recruiting
Phase 3, Not Applicable, Phase 1, Phase 2
Arthritis, Gouty
0 Actively Recruiting
Nephrotic Syndrome
11 Actively Recruiting
Phase 2, Not Applicable, Phase 3
Rheumatoid Arthritis
61 Actively Recruiting
Not Applicable, Phase 4, Phase 3, Phase 2, Phase 1
Adrenal Insufficiency
1 Actively Recruiting
Not Applicable
Acute Rheumatic Fever
0 Actively Recruiting
Jaundice, Hemolytic
0 Actively Recruiting
Lupus Erythematosus
4 Actively Recruiting
Phase 4, Not Applicable, Phase 1
Bell's Palsy
0 Actively Recruiting

Cortrosyn Reviews: What are patients saying about Cortrosyn?

3Patient Review
8/25/2012
Cortrosyn for Problem with Adrenal Gland
The injection was quite painful and it left a really unpleasant taste in my mouth.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about cortrosyn

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Why is Cortrosyn given?

"Cortrosyn can be administered in different ways depending on what it is being used for. It can be given as an intramuscular injection or as a direct intravenous injection for a quick test of adrenal function. It can also be given as an intravenous infusion over a period of 4 to 8 hours to provide a greater stimulus to the adrenal glands."

Answered by AI

What does Cortrosyn treat?

"Cortrosyn is a man-made version of a natural substance made by the body called ACTH. It is used to diagnose problems with the adrenal gland, such as Addison's disease or insufficiency caused by corticosteroid use. Cortrosyn is available in generic form."

Answered by AI

What kind of drug is Cortrosyn?

"Cortrosyn is a prescription medicine used as a diagnostic tool for adrenocortical insufficiency. Cortrosyn may be used alone or with other medications. Cortrosyn belongs to a class of drugs called diagnostic tools, specifically for endocrine conditions."

Answered by AI

What is cosyntropin used for?

"Cosyntropin is a man-made copy of a hormone that is used to test patients for adrenal gland problems. This testing is the best way to diagnose adrenal gland problems."

Answered by AI

Clinical Trials for Cortrosyn

Have you considered Cortrosyn clinical trials? We made a collection of clinical trials featuring Cortrosyn, we think they might fit your search criteria.
Have you considered Cortrosyn clinical trials? We made a collection of clinical trials featuring Cortrosyn, we think they might fit your search criteria.
Have you considered Cortrosyn clinical trials? We made a collection of clinical trials featuring Cortrosyn, we think they might fit your search criteria.